Atlas Brown,Inc. Gilead Sciences, Inc. Transaction History

Atlas Brown,Inc.

$284 Million
Q3 2024

A detailed history of Atlas Brown,Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Atlas Brown,Inc. holds 3,455 shares of GILD stock, worth $309,257. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,455

Previous 3,430 0.73%

Holding current value

$309,257

Previous $235,000 22.98%

% of portfolio

0.1%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$66.59 - $83.99 $1,664 - $2,099	25 Added 0.73%	3,455 $289,000
Q2 2024 Jul 23, 2024	BUY	$63.15 - $72.88 $631 - $728	10 Added 0.29%	3,430 $235,000
Q1 2024 Apr 08, 2024	BUY	$71.58 - $87.29 $715 - $872	10 Added 0.29%	3,420 $250,000
Q4 2022 Jan 05, 2023	SELL	$62.32 - $89.47 $453,440 - $650,983	-7,276 Reduced 68.09%	3,410 $0
Q3 2022 Oct 06, 2022	BUY	$59.54 - $68.01 $6,489 - $7,413	109 Added 1.03%	10,686 $659,000
Q2 2022 Jul 15, 2022	BUY	$57.72 - $65.01 $2,712 - $3,055	47 Added 0.45%	10,577 $654,000
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $26,874 - $33,677	-464 Reduced 4.22%	10,530 $626,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $44,896 - $50,958	692 Added 6.72%	10,994 $798,000
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $41,493 - $44,767	613 Added 6.33%	10,302 $720,000
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $188,061 - $205,484	2,963 Added 44.05%	9,689 $667,000
Q1 2021 Apr 13, 2021	SELL	$60.0 - $68.46 $37,980 - $43,335	-633 Reduced 8.6%	6,726 $435,000
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $32,857 - $37,439	580 Added 8.56%	7,359 $429,000
Q3 2020 Oct 15, 2020	BUY	$62.1 - $78.08 $7,452 - $9,369	120 Added 1.8%	6,779 $428,000
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $13,310 - $15,456	184 Added 2.84%	6,659 $507,000
Q1 2020 Apr 16, 2020	BUY	$62.63 - $80.22 $77,285 - $98,991	1,234 Added 23.55%	6,475 $484,000
Q4 2019 Jan 14, 2020	BUY	$61.62 - $67.78 $121,329 - $133,458	1,969 Added 60.18%	5,241 $341,000
Q3 2019 Oct 29, 2019	SELL	$62.51 - $69.0 $15,940 - $17,595	-255 Reduced 7.23%	3,272 $207,000
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $7,919 - $8,880	128 Added 3.77%	3,527 $238,000
Q1 2019 Apr 12, 2019	BUY	$62.53 - $70.05 $3,814 - $4,273	61 Added 1.83%	3,399 $221,000
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $237,801 - $310,312	-3,928 Reduced 54.06%	3,338 $209,000
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $19,530 - $21,624	-274 Reduced 3.63%	7,266 $561,000
Q2 2018 Jul 11, 2018	SELL	$64.88 - $75.68 $29,779 - $34,737	-459 Reduced 5.74%	7,540 $579,000
Q1 2018 Apr 17, 2018	BUY	$72.84 - $88.8 $3,787 - $4,617	52 Added 0.65%	7,999 $603,000
Q4 2017 Jan 25, 2018	BUY	$71.15 - $83.52 $3,699 - $4,343	52 Added 0.66%	7,947 $646,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $569,308 - $674,785	7,895	7,895 $640,000

Others Institutions Holding GILD

# of Institutions

1,903

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $112B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Brown,Inc. with notifications on news.

Account